PrognomiQ
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data. PrognomiQ raised US$34M in Series D funding.
Email and contact information
Company website: prognomiq.com
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: San Mateo, (United States)
Industry: Biotechnology
Business model: B2B
Funding
- Total funding amount: $34,000,000 (in USD)
- Estimated valuation: $170,000,000.00
- Latest deal type: Series D
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK